🔎 Trials Near Me

Home › Kanser sa Prostate › Wisconsin

Pag-aaral pangklinika para sa Kanser sa Prostate sa Wisconsin

47 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa Wisconsin.

Mga Lungsod sa Wisconsin

Opisyal na teksto ng pag-aaral (English)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
  • at 13 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 13, 2026 · NCT04423211

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Nob 12, 2026 · NCT05691465

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Duluth Clinic Ashland, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • at 25 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Zablocki Veterans Administration Medical Center, Milwaukee
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898

WATER IV PCa (AS Sub-study)

  • Advocate Aurora Research Institute, Sheboygan
Nagre-recruit
Edad 45 pataas · Kalalakihan · Na-update Nob 6, 2026 · NCT07650448

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

  • University of Wisconsin-Madison, Madison
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Nob 6, 2026 · NCT06141993

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • at 50 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Marshfield Medical Center-Marshfield, Marshfield
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06632977

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
  • at 26 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Nob 3, 2026 · NCT06931340

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • University Hospital and UW Health Clinics ( Site 0065), Madison
  • Medical College of Wisconsin ( Site 0008), Milwaukee
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 30, 2026 · NCT06925737

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Wisconsin Carbone Cancer Center, Madison
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 29, 2026 · NCT05519449

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • at 36 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 23, 2026 · NCT05946213

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin-Madison, Madison
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Okt 22, 2026 · NCT04489719

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • University of Wisconsin, Madison
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT07103018

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Medical College of Wisconsin ( Site 0020), Milwaukee
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06136650

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06582017

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Kalalakihan · Na-update Okt 15, 2026 · NCT06855277

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT07028853

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

  • Mayo Clinic Health System-Eau Claire, Eau Claire
  • Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Okt 14, 2026 · NCT06325046

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Langlade Hospital and Cancer Center, Antigo
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • Marshfield Medical Center-Marshfield, Marshfield
  • at 14 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 8, 2026 · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Wisconsin, Carbone Cancer Center, Madison
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05919264

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

PET/CT Characterization of Treatment Resistance

  • University of Wisconsin, Madison
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Okt 1, 2026 · NCT05647564

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Medical College Of Wisconsin, Milwaukee
Nagre-recruitPhase 2/3
Edad 18 hanggang 100 · Kalalakihan · Na-update Set 22, 2026 · NCT06780670

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

  • Carbone Cancer Center University of Wisconsin-Madison, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 15, 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • University of Wisconsin, Madison
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT06056830

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 9, 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • UW Health Carbone Cancer Center, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 3, 2026 · NCT07005154

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kalalakihan · Na-update Ago 27, 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • University of Wisconsin Carbone Cancer Center-Madison, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 21, 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

  • Froedtert Hospital, Milwaukee
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07227077

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 31, 2026 · NCT06613100

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • at 10 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Using FAPI PET/MRI to Evaluate Prostate Cancer

  • University of Wisconsin, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06675357

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Kalalakihan · Na-update May 22, 2026 · NCT03151629

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.